You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Details for New Drug Application (NDA): 017604


✉ Email this page to a colleague

« Back to Dashboard


NDA 017604 describes NALFON, which is a drug marketed by Key Therap and Dista and is included in two NDAs. It is available from four suppliers. Additional details are available on the NALFON profile page.

The generic ingredient in NALFON is fenoprofen calcium. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the fenoprofen calcium profile page.
Summary for 017604
Tradename:NALFON
Applicant:Key Therap
Ingredient:fenoprofen calcium
Patents:0
Pharmacology for NDA: 017604
Mechanism of ActionCyclooxygenase Inhibitors
Medical Subject Heading (MeSH) Categories for 017604
Suppliers and Packaging for NDA: 017604
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NALFON fenoprofen calcium CAPSULE;ORAL 017604 NDA AUTHORIZED GENERIC Gentex Pharma 15014-400 15014-400-60 60 CAPSULE in 1 BOTTLE (15014-400-60)
NALFON fenoprofen calcium CAPSULE;ORAL 017604 NDA AUTHORIZED GENERIC Gentex Pharma 15014-400 15014-400-90 90 CAPSULE in 1 BOTTLE (15014-400-90)

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrengthEQ 300MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrengthEQ 200MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrengthEQ 400MG BASE
Approval Date:Jul 21, 2009TE:RLD:Yes

Expired US Patents for NDA 017604

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Key Therap NALFON fenoprofen calcium CAPSULE;ORAL 017604-002 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Key Therap NALFON fenoprofen calcium CAPSULE;ORAL 017604-003 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.